We are live on
!
Find out more
Clearstead Advisors Portfolio holdings
AUM
$10.6B
Turnover
42.91%
1-Year Est. Return
24.87%
This Fund
S&P 500
This Quarter
Est. Return
+14.75%
1 Year Est. Return
+24.87%
3 Year Est. Return
+71.44%
5 Year Est. Return
+80.35%
10 Year Est. Return
–
AUM
$10.6B
AUM Growth
-$353M
(-3.2%)
Cap. Flow
-$277M
Cap. Flow
% of AUM
-2.62%
Top 10 Holdings %
Top 10 Hldgs %
28.93%
Holding
3,754
New
1,518
Increased
1,198
Reduced
637
Closed
93
Avg Time Held Equity + Options
2
years
Top 10 Avg Time Held Equity + Options
3
years
Top 20 Avg Time Held Equity + Options
3
years
Avg Time Held Equity only
2
years
Top 10 Avg Time Held Equity only
3
years
Top 20 Avg Time Held Equity only
3.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$967M |
| 2 |
NVIDIA
NVDA
|
+$132M |
| 3 |
Baillie Gifford Long Term Global Growth ETF
BGGG
|
+$122M |
| 4 |
Sonoco
SON
|
+$35.5M |
| 5 |
Xtrackers USD High Yield Corporate Bond ETF
HYLB
|
+$23.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PACCAR
PCAR
|
+$287M |
| 2 |
Microsoft
MSFT
|
+$137M |
| 3 |
iShares Core MSCI International Developed Markets ETF
IDEV
|
+$124M |
| 4 |
Dimensional International High Profitability ETF
DIHP
|
+$84.2M |
| 5 |
Starbucks
SBUX
|
+$73.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 61.29% |
| 2 | Technology | 11.98% |
| 3 | Industrials | 7.46% |
| 4 | Financials | 5.38% |
| 5 | Consumer Discretionary | 3.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3151
Exzeo Group
XZO
$1.5B
| $237 | ﹤0.01% |
+14
| New | +$206 |
2026 Q2
0 quarters
|
|
3152
Liberty Energy
LBRT
$2.73B
| $236 | ﹤0.01% |
+9
| New | +$269 |
2026 Q2
0 quarters
|
|
3153
SolarEdge
SEDG
$1.93B
| $234 | ﹤0.01% |
+4
| New | +$210 |
2026 Q2
0 quarters
|
|
3154
AudioEye
AEYE
$88M
| $233 | ﹤0.01% |
+40
| New | +$278 |
2026 Q2
0 quarters
|
|
3155
Coastal Financial
CCB
$657M
| $233 | ﹤0.01% |
+3
| New | +$225 |
2026 Q2
0 quarters
|
|
3156
Inogen
INGN
$167M
| $233 | ﹤0.01% |
36
+8
| +29% | +$53 |
2022 Q1
17 quarters
|
|
3157
Silvercrest Asset Management
SAMG
$83.4M
| $233 | ﹤0.01% |
23
-10,592
| -100% | -$129K |
2024 Q2
8 quarters
|
|
3158
Wolverine World Wide
WWW
$1.64B
| $232 | ﹤0.01% |
+14
| New | +$237 |
2026 Q2
0 quarters
|
|
3159
Aeva Technologies
AEVA
$766M
| $231 | ﹤0.01% |
+8
| New | +$157 |
2026 Q2
0 quarters
|
|
3160
iShares MSCI United Kingdom ETF
EWU
$3.77B
| $231 | ﹤0.01% |
5
| – | – |
2026 Q1
1 quarter
|
|
3161
Forward Air
FWRD
$535M
| $231 | ﹤0.01% |
+17
| New | +$253 |
2026 Q2
0 quarters
|
|
3162
OrthoPediatrics
KIDS
$589M
| $231 | ﹤0.01% |
+12
| New | +$209 |
2026 Q2
0 quarters
|
|
3163
Defiance Daily Target 2x Long MSTR ETF
MSTX
$349M
| $231 | ﹤0.01% |
31
| – | – |
2025 Q3
3 quarters
|
|
3164
AMC Global Media
AMCX
$446M
| $230 | ﹤0.01% |
+23
| New | +$204 |
2026 Q2
0 quarters
|
|
3165
Installed Building Products
IBP
$5B
| $230 | ﹤0.01% |
+1
| New | +$243 |
2026 Q2
0 quarters
|
|
3166
Kymera Therapeutics
KYMR
$8.99B
| $230 | ﹤0.01% |
+2
| New | +$172 |
2026 Q2
0 quarters
|
|
3167
Uniti Group
UNIT
$1.46B
| $230 | ﹤0.01% |
+20
| New | +$227 |
2026 Q2
0 quarters
|
|
3168
Pacira BioSciences
PCRX
$1.45B
| $229 | ﹤0.01% |
+9
| New | +$213 |
2026 Q2
0 quarters
|
|
3169
VSE Corp
VSEC
$4.53B
| $229 | ﹤0.01% |
+1
| New | +$192 |
2026 Q2
0 quarters
|
|
3170
Willis Lease Finance
WLFC
$813M
| $229 | ﹤0.01% |
+3
| New | +$196 |
2026 Q2
0 quarters
|
|
3171
Kestra Medical Technologies
KMTS
$1.71B
| $229 | ﹤0.01% |
+9
| New | +$188 |
2026 Q2
0 quarters
|
|
3172
Hippo Holdings
HIPO
$930M
| $227 | ﹤0.01% |
+8
| New | +$213 |
2026 Q2
0 quarters
|
|
3173
Aardvark Therapeutics
AARD
$84.5M
| $226 | ﹤0.01% |
+39
| New | +$182 |
2026 Q2
0 quarters
|
|
3174
DELISTED
Crinetics Pharmaceuticals
CRNX
| $225 | ﹤0.01% |
+6
| New | +$223 |
2026 Q2
0 quarters
|
|
3175
Koppers
KOP
$822M
| $225 | ﹤0.01% |
+5
| New | +$205 |
2026 Q2
0 quarters
|
|
Similar funds
Clearstead Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Clearstead Advisors held 3,754 positions worth $10.6B, down 3.2% from $10.9B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Clearstead Advisors's Q2 2026 filing shows 1,518 new, 1,198 increased, 637 reduced and 93 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 1,450,939 shares worth $997M. The largest sale was PACCAR, an estimated $287M.
By sector, the portfolio is most concentrated in Miscellaneous at 61% of assets, up from 61% a quarter earlier, followed by Technology and Industrials.
- Clearstead Advisors's largest Q2 2026 buy was Vanguard S&P 500 ETF: 1,450,939 shares worth $997M.
- Clearstead Advisors added most to Sonoco in Q2 2026, an estimated $35.5M increase.
- Clearstead Advisors's biggest Q2 2026 reduction was PACCAR, cutting an estimated $287M.
- Clearstead Advisors fully exited iShares Currency Hedged MSCI Japan ETF in Q2 2026, selling an estimated $9.02M.
- Clearstead Advisors's ten largest holdings make up 29% of its $10.6B portfolio in Q2 2026.
- Clearstead Advisors opened 1,518 new positions and closed 93 in Q2 2026.
- Clearstead Advisors's portfolio value fell 3.2% quarter-over-quarter to $10.6B.
Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.